-
MIT Technology Review |
For starters, it's too expensive and the science isn't advanced enough.
Jul 18, 2016
-
Xconomy |
Imagine you could go to your doctor once a year for a blood test that would detect nearly every common type of cancer at an early stage. A lot of companies are working on that type of molecular diagnostic, but is it still too early to expect that test?
Jul 18, 2016
-
Diagnostics World | The American Medical Association (AMA), in partnership with Scripps Translational Science Institute (Scripps) and The Jackson Laboratory (JAX), have announced a new online program aimed at educating physicians and other health care professionals on the benefits and limitations of genetic testing and when it is appropriate to incorporate it into their practices.
Jul 14, 2016
-
New England Journal of Medicine | In a letter to the editor, Diana Bianchi and two Illumina scientists present updated screening test results for the CARE cohort using updated technology, and finds that there were both technological and biological reasons for false positives
Jul 13, 2016
-
Diagnostics World News | Diagnostic news and product launches include prostate cancer diagnostic test gets expanded coverage, Baylor University partners on a Hong Kong center for medical genetics, and Sure Genomics launches a family health app.
Jul 12, 2016
-
The New York Times |
U.S. regulators also revoked the operating license of a Theranos lab and levied a fine. The sanctions were a major setback for the once high-flying blood-testing start-up.
Jul 8, 2016
-
Diagnostics World Ranomics is capturing attention with its database of genomic variants. Counting BGI and Veritas among its new customers, the Toronto-based biotech startup plans to model and test every missense mutation to make genetic tests "more accurate and more conclusive than ever."
Jul 7, 2016
-
Diagnostics World News | The introduction of exome and whole-genome sequencing in 2010 has accelerated the discovery of genes underlying Mendelian disorders. However delineating new Mendelian conditions by comparing phenotypic traits across families is still challenging, especially with limited sharing of health and genetic data among researchers. Researchers at the University of Washington have launched a new data sharing platform to bring family expertise to the table.
Jul 5, 2016
-
Diagnostics World Brief | WuXi NextCODE’s genomics platform is now available on Microsoft Azure. The platform has previously been available on Amazon Web Services and Huawei in China.
Jun 27, 2016
-
Diagnostics World Brief | MolecularMD Corporation and Illumina are working together to establish a framework for potential collaborations with respect to the development and commercialization of sequencing-based companion diagnostics in support of biopharma drug development programs. The agreement announced today dovetails MolecularMD's companion diagnostic development and FDA submission experience with Illumina's NGS technology.
Jun 27, 2016
-
Diagnostics World | Matchmaker Exchange (MME) aims to create a network that connects several isolated rare disease databases using a common application programming interface (API) that supports queries and responses. If it can provide researchers and clinicians with data from just one more case with a deleterious variant in the same gene and phenotypic features in common, MME may offer sufficient evidence to identify the causative gene for a specific rare disease.
Jun 23, 2016
-
Becker's Hospital Review |
Madison, N.J.-based Quest Diagnostics announced a partnership last week with grocery chain Safeway that will bring diagnostic testing to 12 grocery stores in California, Colorado, Texas, Virginia and Maryland.
Jun 23, 2016
-
Xconomy |
So far, the story of IBM Watson Health has been mostly about growth and potential. Today, it's more about action. The healthcare computing giant is unveiling a collaborative effort in medical imaging that includes partnerships with health systems, radiology providers, tech companies, and academic medical centers.
Jun 22, 2016
-
Diagnostics World | Kailos Genetics and the Huntsman Cancer Institute (HCI) at the University of Utah have won a $2.4 million grant from the National Institutes of Health to develop a clinical-grade test for circulating tumor DNA (ctDNA) to monitor patients for breast cancer disease recurrence.
Jun 22, 2016
-
MIT Technology Review |
The Tech Review editors pick the 50 companies that best combine innovative technology with an effective business model. Several diagnostics and biotech companies make the list, including T2 Biosystems (#34), Oxford Nanopore (#22), and Veritas (#40).
Jun 21, 2016
-
Diagnostics World News | On Friday, the U.S. Food and Drug Administration (FDA) granted emergency use authorization for Hologic’s new, diagnostic assay for Zika virus infection.
Jun 20, 2016
-
Forbes |
Elizabeth Holmes speaking at the Forbes Healthcare Summit last December. Credit: Glen Davis If there is working technology at Theranos, the embattled startup that promised to revolutionize blood tests by replacing needles in veins with finger pricks at a lower price with faster speed, you wouldn't be able to tell. To [...]
Jun 17, 2016